Eutylone
β-Keto-1,3-benzodioxolyl-N-ethylbutanamine (Eutylone, bk-EBDB, N-Ethylbutylone) is a stimulant compound developed in the 1960s,[1] which has been reported as a novel designer drug.[2]
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C13H17NO3 |
Molar mass | 235.283 g·mol−1 |
3D model (JSmol) | |
| |
| |
|
Legal status
Sweden's public health agency suggested classifying Eutylone as a hazardous substance, on September 25, 2019.[3]
gollark: You'd keep the vagueness and be not entirely useless!
gollark: "Do not reverse engineer, blahblah - don't do X Y Z or similar"
gollark: Anyway, even with the vague phrasing kept, some sort of extra clarity would be nice.
gollark: Many of the hub rules had/have to be extrapolated from the T&C... it was a stupider time.
gollark: Eeeh, sort of, but "no deducing anything about how the site works" seems a bit stupid.
References
- Substituted phenyl-α-amino ketones. British Patent GB 1085135 (1969).
- "Eutylone". New Synthetic Drugs Database.
- "Tretton ämnen föreslås klassas som narkotika eller hälsofarlig vara" (in Swedish). Folkhälsomyndigheten. 25 September 2019.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.